Disease progression in Parkinson subtypes: the PPMI dataset

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Neurological Sciences

• Publication date

  2018-08-14

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s10072-018-3522-zPMID 30109466
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical criteria for subtyping Parkinson’s disease: biomarkers and longitudinal progression

  2017cited by this paper
• How stable are Parkinson's disease subtypes in de novo patients: Analysis of the PPMI cohort?

  2016cited by this paper
• Cognitive decline in Parkinson’s disease: the complex picture

  2016cited by this paper
• Association of cognitive domains with postural instability/gait disturbance in Parkinson's disease.

  2015cited by this paper
• Diagnosis of Parkinson's disease on the basis of clinical and genetic classification: a population-based modelling study.

  2015cited by this paper
• Clinical variables associated with treatment changes in Parkinson’s disease: results from the longitudinal phase of the REASON study

  2015cited by this paper
• How to identify tremor dominant and postural instability/gait difficulty groups with the movement disorder society unified Parkinson's disease rating scale: Comparison with the unified Parkinson's disease rating scale

  2013cited by this paper
• Mild cognitive impairment and cognitive-motor relationships in newly diagnosed drug-naive patients with Parkinson's disease

  2012cited by this paper
• Clinical subtypes of Parkinson's disease

  2011cited by this paper
• Postural instability/gait disturbance in Parkinson's disease has distinct subtypes: an exploratory analysis

  2010cited by this paper
• Changes in motor subtype and risk for incident dementia in Parkinson's disease

  2006cited by this paper
• Motor subtype and cognitive decline in Parkinson’s disease, Parkinson’s disease with dementia, and dementia with Lewy bodies

  2006cited by this paper
• The heterogeneity of idiopathic Parkinson's disease

  2002cited by this paper
• Random-effects models for longitudinal data.

  1982cited by this paper

• Morpho-functional correlates of gait impairment in early Parkinson's disease patients: insights from a multimodal path modeling framework.

  2026cites this paper
• Associations among blood biomarkers, clinical subtypes, and prognosis in Parkinson’s disease

  2025cites this paper
• The challenges with the identification of Parkinson’s disease subtypes

  2025cites this paper
• Cognitive function in different motor subtypes of Parkinson’s disease: A systematic review and multilevel meta-analysis

  2025influential citation
• The Results of a 12-Month Open-Label Follow-Up Study with MRI Monitoring of Patients with Parkinson’s Disease After MRI-Guided FUS

  2025cites this paper
• Aerobic exercise modulates plasma oxidized lipid metabolites and neurotransmitters in Parkinson's disease motor subtypes.

  2025cites this paper
• Prognostic Value of Parkinson's Disease Subtypes in the LABS-PD Cohort: Functional Ability, Quality of Life and Mortality.

  2025cites this paper
• Variations in ADAR editing of nonsense-mediated decay targets in PD males and females

  2025cites this paper
• M2KD-Net: A multimodal multi-domain knowledge-driven framework for Parkinson's disease diagnosis

  2025cites this paper
• Body composition and resting metabolic rate in Parkinson's disease: A prospective cross-sectional single centre study.

  2025cites this paper
• Objective monitoring of motor symptom severity and their progression in Parkinson’s disease using a digital gait device

  2025cites this paper
• Regional-specific structural and functional changes of posterior cerebellar vermis across different stages of Parkinson’s disease with gait dysfunction

  2025cites this paper
• A novel fusion architecture for detecting Parkinson’s Disease using semi-supervised speech embeddings

  2025cites this paper
• Using prodromal non-motor symptoms to predict Parkinson’s disease onset and motor phenotype

  2025cites this paper
• Unraveling Parkinson's disease motor subtypes: A deep learning approach based on spatiotemporal dynamics of EEG microstates.

  2025cites this paper
• Longitudinal assessment of DNA repair signature trajectory in prodromal versus established Parkinson’s disease

  2025cites this paper
• Longitudinal Assessment of Parkinson’s Motor Symptoms and Dopaminergic Dysfunction Patterns Using DaTSCAN

  2025influential citation
• Coupling between beta band and high frequency oscillations as a clinically useful biomarker for DBS

  2024cites this paper
• A biomechanical analysis of turning during gait in individuals with different subtypes of Parkinson's disease.

  2024cites this paper
• Association of motor subtype and tremor type with Parkinson's disease progression: An exploratory longitudinal analysis

  2024cites this paper
• Machine learning analysis of population-wide plasma proteins identifies hormonal biomarkers of Parkinson’s Disease

  2024cites this paper
• Disease Progression Modelling and Stratification for Detecting Sub-trajectories in the Natural History of Pathologies: Application to Parkinson's Disease Trajectory Modelling

  2024cites this paper
• -Structural Changes in Early-stage Parkinson's Disease with Resting Tremor at Node, Edge and Network Level.

  2024cites this paper
• Medication recommendation for Parkinson’s disease based on dynamics of symptom progression

  2024cites this paper
• Impaired Gait, Postural Instability, and Rigidity in Relation to CB1 Receptor Availability in Parkinson's Disease

  2024cites this paper
• From Prodromal Stages to Clinical Trials: The Promise of Digital Speech Biomarkers in Parkinson's Disease.

  2024cites this paper
• Comparing smell identification ability among different motor subtypes of Parkinson’s disease using the Vietnamese Smell Identification Test and the Brief Smell Identification Test

  2024cites this paper
• Tremor-Dominant Form of Parkinson’s Disease

  2024cites this paper
• Unraveling the threads of stability: A review of the neurophysiology of postural control in Parkinson's disease

  2024cites this paper
• An Examination of Cognitive Heterogeneity in Parkinson Disease: The Dual-Syndrome Hypothesis.

  2024cites this paper
• Plasma GFAP as a prognostic biomarker of motor subtype in early Parkinson’s disease

  2024cites this paper
• Reduction in variability of dopamine transporter measures using SPECT and ultra-high-resolution fan beam collimators: comparison with parallel-hole collimators in healthy controls for a clinical reference database

  2024cites this paper
• Federated learning for cross-institution brain network analysis

  2024cites this paper
• Circulating plasma miR-23b-3p as a biomarker target for idiopathic Parkinson's disease: comparison with small extracellular vesicle miRNA

  2023cites this paper
• IgA-Biome Profiles Correlate with Clinical Parkinson’s Disease Subtypes

  2023cites this paper
• Modulatory effect of levodopa on the basal ganglia-cerebellum connectivity in Parkinson’s disease

  2023cites this paper
• Distribution pattern of iron deposition in the basal ganglia of different motor subtypes of Parkinson's disease.

  2023cites this paper
• Updated Parkinson's disease motor subtypes classification and correlation to cerebrospinal homovanillic acid and 5-hydroxyindoleacetic acid levels

  2023cites this paper
• Tinetti balance performance is associated with mortality in older adults with late-onset Parkinson’s disease: a longitudinal study

  2023cites this paper
• White and gray matter alterations in de novo PD patients: which matter most?

  2023cites this paper
• How should future clinical trials be designed in the search for disease-modifying therapies for Parkinson’s disease?

  2023cites this paper
• To lump or to split? Deep brain stimulation may improve non-motor symptoms in certain Parkinson's disease subtypes.

  2023cites this paper
• Clinical features of minor hallucinations in different phenotypes of Parkinson’s disease: A cross-sectional study

  2023cites this paper
• Circadian profile, daytime activity, and the Parkinson's phenotype: A motion sensor pilot study with neurobiological underpinnings.

  2023cites this paper
• Cerebrospinal fluid alpha-synuclein, amyloid beta, total tau, and phosphorylated tau in tremor-dominant Parkinson’s disease

  2023cites this paper
• The severity of corneal nerve loss differentiates motor subtypes in patients with Parkinson’s disease

  2023cites this paper
• PTGB: Pre-Train Graph Neural Networks for Brain Network Analysis

  2023cites this paper
• Volumetric changes and clinical trajectories in Parkinson’s disease: a prospective multicentric study

  2023cites this paper
• Multifactorial assessment of Parkinson’s disease course and outcomes using trajectory modeling in a multiethnic, multisite cohort – extension of the LONG-PD study

  2023cites this paper
• Free water imaging unravels unique patterns of longitudinal structural brain changes in Parkinson’s disease subtypes

  2023cites this paper
• FedBrain: Federated Training of Graph Neural Networks for Connectome-based Brain Imaging Analysis.

  2023cites this paper
• Charting Disease Trajectories from Isolated REM Sleep Behavior Disorder to Parkinson's Disease

  2023cites this paper
• Baseline predictors of progression of Parkinson’s disease in a sample of Egyptian patients: clinical and biochemical

  2022cites this paper
• DBSegment: Fast and robust segmentation of deep brain structures considering domain generalization

  2022cites this paper
• Study in Parkinson’s disease of exercise phase 3 (SPARX3): study protocol for a randomized controlled trial

  2022cites this paper
• Profiles of Motor-Cognitive Interference in Parkinson’s Disease—The Trail-Walking-Test to Discriminate between Motor Phenotypes

  2022cites this paper
• Tremor in Parkinson’s Disease: From Pathophysiology to Advanced Therapies

  2022cites this paper
• What Is the Role of Dopamine Transporter Imaging in Parkinson Prevention Clinical Trials?

  2022cites this paper
• Interplay between gait and neuropsychiatric symptoms in Parkinson’s Disease

  2022cites this paper
• Levodopa ONOFF-state freezing of gait: Defining the gait and non-motor phenotype

  2022cites this paper
• Combining biomarkers for prognostic modelling of Parkinson’s disease

  2022cites this paper
• The emerging postural instability phenotype in idiopathic Parkinson disease

  2022cites this paper
• The emerging postural instability phenotype in idiopathic Parkinson disease

  2022cites this paper
• Parkinson’s Disease Subtyping Using Clinical Features and Biomarkers: Literature Review and Preliminary Study of Subtype Clustering

  2022cites this paper
• Variable Effects of PD-Risk Associated SNPs and Variants in Parkinsonism-Associated Genes on Disease Phenotype in a Community-Based Cohort

  2021cites this paper
• Concomitant improvement in anti-saccade success rate and postural instability gait difficulty after rTMS treatment for Parkinson’s disease

  2021cites this paper
• Multi-omic insights into Parkinson's Disease: From genetic associations to functional mechanisms.

  2021cites this paper
• Serum neurofilament light as a biomarker for prognosis in patients with newly diagnosed Parkinson disease

  2021cites this paper
• Longitudinal clustering analysis and prediction of Parkinson's disease progression using radiomics and hybrid machine learning.

  2021cites this paper
• DBSegment: Fast and robust segmentation of deep brain structures - Evaluation of transportability across acquisition domains

  2021cites this paper
• Motor Progression in Early-Stage Parkinson's Disease: A Clinical Prediction Model and the Role of Cerebrospinal Fluid Biomarkers

  2021cites this paper
• Disentangling the PIGD classification for the prediction of cognitive impairment in de novo Parkinson’s disease

  2021cites this paper
• Fiber-specific white matter alterations in early-stage tremor-dominant Parkinson’s disease

  2021cites this paper
• A feasibility study of dual-task strategy training to improve gait performance in patients with Parkinson’s disease

  2021cites this paper
• Artificial intelligence applied to neuroimaging data in Parkinsonian syndromes: Actuality and expectations.

  2021cites this paper
• Immunization therapies for Parkinson’s disease: state of the art and considerations for future clinical trials

  2020cites this paper
• Parkinson’s disease subtypes: literature review

  2020cites this paper
• Corneal confocal microscopy detects small fibre neurodegeneration in Parkinson's disease using automated analysis

  2020cites this paper
• Association Analyses of Autonomic Dysfunction and Sympathetic Skin Response in Motor Subtypes of Parkinson's Disease

  2020cites this paper
• Self-perceptions of speech, voice, and swallowing in motor phenotypes of Parkinson's disease

  2020cites this paper
• Differential Gait Decline in Parkinson’s Disease Enhances Discrimination of Gait Freezers from Non-Freezers

  2020cites this paper
• Unsupervised clustering of dopamine transporter PET imaging discovers heterogeneity of parkinsonism

  2020cites this paper
• Longitudinal Monitoring of Parkinson's Disease in Different Ethnic Cohorts: The DodoNA and LONG-PD Study

  2020cites this paper
• Parkinson’s disease: etiopathogenesis and treatment

  2020cites this paper
• Utility of plasma Neurofilament light as a diagnostic and prognostic biomarker of the postural instability gait disorder motor subtype in early Parkinson’s disease

  2020cites this paper
• Altered Body Composition and Increased Resting Metabolic Rate Associated with the Postural Instability/Gait Difficulty Parkinson's Disease Subtype

  2020cites this paper
• BDNF Val 66 Met polymorphism and cognitive impairment in Parkinson ’ s disease — a meta-analysis

  2019cites this paper
• Apathy as a behavioural marker of cognitive impairment in Parkinson’s disease: a longitudinal analysis

  2019cites this paper
• Subtyping of Parkinson’s Disease - Where Are We Up To?

  2019cites this paper
• More Research Is Needed on Lifestyle Behaviors That Influence Progression of Parkinson's Disease

  2019cites this paper
• Comparing postural instability and gait disorder and akinetic‐rigid subtyping of Parkinson disease and their stability over time

  2019cites this paper
• BDNF Val66Met polymorphism and cognitive impairment in Parkinson’s disease—a meta-analysis

  2019cites this paper
• Demographic and clinical variables as differentiating predictors of cognitive disorders in Parkinson’s disease

  2019cites this paper
• Olfactory Identification among Various Subtypes of Parkinson Disease

  2019cites this paper
• Risk thresholds of levodopa dose for dyskinesia in Chinese patients with Parkinson’s disease: a pilot study

  2019cites this paper
• second brain first

  year unknowncites this paper